Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
Abstract:
In vitro methods such as in vitro diagnosis, prognosis and risk stratification of a patient having a primary disease, whereby the level of Procalcitonin (PCT) or fragment thereof in a sample of a bodily fluid of the patient is indicative for the risk of the patient to contract a further disease or medical condition. Assays for performing such methods and samples containing complex resulting from such methods.
Information query
Patent Agency Ranking
0/0